Key takeaways
- Oxytocin is a ring-shaped peptide of nine amino acids, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, closed by a bond between its two cysteines.
- It is made mainly in the hypothalamus and released from the posterior pituitary; a 2001 review lists its classical actions as contraction of the uterus in labour and milk ejection during breastfeeding.
- Synthetic oxytocin is a prescription medicine in the US, UK and Australia; the US label says it is not indicated for elective induction of labour.
- Nasal-spray studies of social behaviour are mixed: a 2005 trust finding did not hold in a large 2020 registered replication, and a 2021 trial in 290 children and adolescents with autism found no difference from placebo.
- Oxytocin is not named on WADA’s 2026 or 2027 Prohibited List; WADA’s notes on the 2027 List say a peptide not specifically named “may still be prohibited”, and anti-doping organisations decide how the List applies.
01Oxytocin at a glance
The short version, dated 18 November 2026. Every line is sourced at the end of the page.
| Question | Oxytocin |
|---|---|
| What it is | A hormone of nine amino acids, made mainly in the hypothalamus and released into the blood from the posterior pituitary. Some other tissues, including the uterus and placenta, also make it. |
| Structure | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, with a disulfide bond between the two cysteines that closes a ring. C43H66N12O12S2, 1007.2 g/mol. |
| Receptor | The oxytocin receptor, a G-protein-coupled receptor. In the uterus, receptor numbers rise greatly during pregnancy (US label). |
| Evidence tier | Approved uses: regulator labels. Social behaviour in people: randomised trials exist (T1), with mixed or null results. Animal studies: T3. |
| United States | Prescription medicine (Pitocin and other products). The one oxytocin nasal spray in Drugs@FDA, Syntocinon, is listed as discontinued. |
| United Kingdom | Prescription-only medicine: five oxytocin products on the emc database, all solutions for infusion. |
| Australia | Schedule 4, Prescription Only Medicine, in the Poisons Standard October 2026. |
| WADA | Not named on the 2026 or 2027 Prohibited List. WADA’s notes on the 2027 List say a peptide not specifically named “may still be prohibited”. |
02What is the oxytocin peptide?
Oxytocin is a peptide hormone of nine amino acids. Two of them are cysteines, and a bond between them closes the first six into a ring; the UK product information calls it “a cyclic nonapeptide”. How peptides like this are built: how peptides work.
Its main site of production is nerve cells in two clusters of the hypothalamus, the paraventricular and supraoptic nuclei. It is released from the posterior pituitary into the blood in response to stimuli such as suckling and labour, according to a 2001 review, which notes that the uterus and placenta also make it. Its receptor is a G-protein-coupled receptor. The review lists its classical actions as contraction of the uterus during labour and milk ejection during breastfeeding.
Oxytocin has a close relative, vasopressin, the hormone that helps the kidneys hold on to water. The US label notes that the two differ in only two amino acids, and the UK product information says oxytocin has “some weak intrinsic vasopressin-like antidiuretic activity” of its own.
In 1953, Vincent du Vigneaud determined its sequence, the first for a peptide hormone, according to the Nobel Prize organisation, and also made it in the laboratory. His 1955 Nobel Prize in Chemistry cited “the first synthesis of a polypeptide hormone”. Oxytocin in medicines today is synthetic and, the UK product information says, identical to the natural hormone.
03What is oxytocin approved for?
Label facts, in the labels’ own terms. We describe what the labels cover, not how the medicine is given.
United States. Pitocin is synthetic oxytocin, sold on prescription. Before birth, its label says it is indicated “for the initiation or improvement of uterine contractions, where this is desirable and considered suitable for reasons of fetal or maternal concern”: to induce labour when there is a medical reason, to strengthen labour in selected cases of uterine inertia (weak contractions), and as an add-on in managing an incomplete or inevitable abortion. After birth, it is indicated “to produce uterine contractions during the third stage of labor and to control postpartum bleeding or hemorrhage”.
The section opens with an “important notice”: Pitocin “is not indicated for elective induction of labor”, meaning induction without a medical reason, because “the available data are inadequate to evaluate the benefits-to-risks considerations”. In labour, the label says, it should be given only “with adequate medical supervision in a hospital”.
United Kingdom. The product information for one UK oxytocin infusion (hameln pharma) covers similar ground: induction of labour for medical reasons, weak contractions, use in caesarean section after the baby is delivered, early pregnancy loss, and bleeding after birth.
04What does the oxytocin label say about risks?
The US label lists serious adverse reactions in the mother and in the baby, and names what has not been studied.
In the mother. Reported reactions include anaphylaxis, irregular heart rhythms, bleeding after birth, bleeding around the brain (subarachnoid haemorrhage), episodes of high blood pressure, rupture of the uterus, a fatal clotting disorder (afibrinogenemia), nausea and vomiting. The label states that “maternal deaths due to hypertensive episodes, subarachnoid hemorrhage, rupture of the uterus, and fetal deaths due to various causes have been reported” with oxytocic drugs used to induce or speed up labour.
Water. Because oxytocin has an antidiuretic effect, the label warns of water intoxication. Severe cases with convulsions and coma have occurred, and “maternal death due to oxytocin-induced water intoxication has been reported”.
In the baby. Listed reactions include a slow or irregular heart rate, low Apgar scores, jaundice, bleeding in the retina, seizures, “permanent CNS or brain damage” and fetal death.
Not studied. The label says there are no animal or human studies of oxytocin’s potential to cause cancer or genetic damage, and no information on its effect on fertility.
More on reading safety records: side effects, documented vs unknown.
05What has research outside the label studied?
Researchers have given oxytocin as a nasal spray to study social behaviour in people, an idea drawn from animal research. The results are mixed.
Animals (T3). In rodents, changing the brain’s oxytocin system altered parental behaviour, social bonding and recognition of other individuals, a 2016 Emory University review notes.
Trust, 2005 (people, controlled trial). A Zurich study used an economic “trust game”. Its authors reported that investors given oxytocin by nasal spray trusted more, a result the 2020 replication team describes as larger “transfers made by investors”. The 2005 abstract does not give the number of participants or describe the comparison group.
The replication, 2020 (T1). A team including an author of the 2005 study ran a large double-blind, placebo-controlled replication, registered in advance, with more than 95% statistical power. It found no effect of oxytocin on trust in the condition that matched the original. An exploratory subgroup finding, its authors wrote, “requires confirmation”.
The reviews. A 2015 critical review concluded that the trust finding “has not replicated well” and that the evidence “does not provide robust convergent evidence” that human trust is linked to oxytocin. The 2016 Emory review judged nasal-spray studies “generally underpowered”, with “a high probability that most of the published intranasal OT findings do not represent true effects”.
A large clinical trial, 2021 (T1, n=290). In a 24-week, placebo-controlled phase 2 trial, 290 children and adolescents aged 3 to 17 with autism were randomly assigned to an oxytocin or a placebo nasal spray. The primary social-withdrawal score did not differ between the groups, and secondary measures generally did not differ either. Adverse events were similar in incidence and severity.
Does it reach the brain? A 2016 Edinburgh review noted that very little of what is sprayed appears to reach the fluid around the brain, while blood levels rise above the natural range, and called claims that blood levels reflect release in the brain “questionable at best”. How we grade studies: evidence grades.
06Is oxytocin a prescription medicine? Status by market
United States. Drugs@FDA lists Pitocin (NDA 018261) and oxytocin products from other makers as prescription products. The one oxytocin nasal spray it holds, Syntocinon (NDA 012285), is listed as discontinued (openFDA, 18 November 2026).
United Kingdom. The emc database lists five oxytocin products, all solutions for infusion, each a prescription-only medicine (18 November 2026). We did not check MHRA’s own product database.
Australia. Oxytocin is in Schedule 4 of the Poisons Standard October 2026, in force from 1 October 2026; medicines in Schedule 4 carry the signal words “Prescription Only Medicine”. The TGA’s product information database lists five medicines containing oxytocin, including Syntocinon (18 November 2026).
Sport. Oxytocin is not named on WADA’s 2026 or 2027 Prohibited List. WADA’s notes on the 2027 List add that “even if a peptide is not specifically named on the List, utmost caution should be taken as it may still be prohibited and may be harmful to health”. Anti-doping organisations decide how the List applies. See peptides and anti-doping, and other compounds’ status in the regulatory tracker.
07What we don’t know about oxytocin
- Whether oxytocin nasal spray changes social behaviour in people. The large trials above found no difference from placebo, and a 2016 analysis judged it highly probable that most published findings do not represent true effects.
- How much sprayed oxytocin reaches the brain, and whether blood levels say anything about the brain.
- Effects over longer periods. The longest trial we cite ran 24 weeks.
- Its potential to cause cancer or genetic damage, and its effect on fertility. The US label lists these as unstudied.
This is a plain-English summary of public documents and studies, checked on 18 Nov 2026. It is not legal or medical advice.